Wolfe Research Downgrades Plains GP Holdings to Peer Perform with No Price Target

Plains GP Holdings (PAGP) has been downgraded by Wolfe Research to 'Peer Perform' from 'Outperform'. The action, announced on July 25, was made by analyst Keith Stanley. The average target price for PAGP is $21.29 with a high estimate of $26.00 and a low estimate of $17.50. The average target implies an upside of 6.03% from the current price of $20.08. The estimated GF Value for PAGP in one year is $14.81, suggesting a downside of 26.25% from the current price.

Plains GP Holdings (PAGP) has been the subject of varied analyst opinions in recent months, with a notable downgrade from Wolfe Research. On July 25, analyst Keith Stanley downgraded PAGP to 'Peer Perform' from 'Outperform', reflecting a shift in the firm's outlook on the company's prospects [1].

The average target price for PAGP currently stands at $21.29, with estimates ranging from a high of $26.00 to a low of $17.50. This average target implies an upside of 6.03% from the current price of $20.08. However, the estimated GF Value for PAGP in one year is $14.81, suggesting a potential downside of 26.25% from the current price [2].

The mixed sentiments among analysts are evident in the recent ratings data. Over the past three months, 8 analysts have provided ratings for PAGP, with 2 analysts recommending a 'Buy', 5 recommending a 'Hold', and 1 recommending a 'Sell'. This indicates a cautious approach from the majority of analysts, with a significant number of them maintaining a neutral stance [2].

Key factors influencing these ratings include the company's cash flow generation, strategic growth initiatives, and recent corporate actions. However, high leverage and market volatility are also cited as risks that could impact PAGP's performance [2].

Financial professionals should closely monitor these developments and consider the implications for PAGP's stock price. Staying informed about analyst ratings and financial indicators is crucial for making well-informed investment decisions.

References:
[1] https://www.benzinga.com/insights/analyst-ratings/25/07/46629224/what-analysts-are-saying-about-plains-gp-holdings-stock
[2] https://www.tipranks.com/stocks/pagp/forecast